How can we help you?
Opportunities and challenges in generating evidence for COVID-19 treatments and vaccines.
We'll help you navigate and understand the emerging ISPOR/ISPE Real World Evidence guidelines.
The consortium working on EMA-funded MINERVA Project to aid RWD use, is being led by RTI-HS
Learn how a Market Access Evidence Roadmap can help you identify areas of evidence generation required to support reimbursement and increase access to your product.
Advice from our experts on best practices for collecting and using patient-experience data during the COVID-19 outbreak.